ZHANG JIANMIAO MIKE
Known title: Senior Vice PresidentCIK: 0002045617
Associated companies
Transaction History
| A | ▼ Sell | Tax Withholding | 208 | $32K | 11/26/2025 | View on chart |
| A | ▼ Sell | Tax Withholding | 67 | $10K | 11/21/2025 | View on chart |
| A | ▲ Buy | Grant | 1,421 | $0 | 11/18/2025 | View on chart |
| A | ▼ Sell | Tax Withholding | 452 | $65K | 11/18/2025 | View on chart |
| A | ▲ Buy | Grant | 5,227 | $0 | 11/18/2025 | View on chart |
| A | ▼ Sell | Tax Withholding | 27 | $4K | 11/14/2025 | View on chart |
| A | ▼ Sell | Tax Withholding | 51 | $7K | 11/14/2025 | View on chart |
| A | ▲ Buy | Grant | 2,569 | $355K | 11/27/2024 | View on chart |
| A | ▼ Sell | Tax Withholding | 65 | $9K | 11/22/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Agilent to acquire Proscia for up to $270M
Agilent Technologies has agreed to acquire digital pathology specialist Proscia in a deal valued at up to $270 million. The move is designed to strengthen Agilent's position in AI-enabled diagnostics and scientific intelligence. Following the announcement, TD Cowen raised its price target for the stock to $196.
Agilent to acquire Proscia for up to $270M. Agilent Technologies has agreed to acquire digital pathology specialist Proscia in a deal valued at up to $270 million. The move is designed to strengthen Agilent's position in AI-enabled diagnostics and scientific intelligence. Following the announcement, TD Cowen raised its price target for the stock to $196.